Cantor Fitzgerald Expects Lower Earnings for Elevance Health

Elevance Health, Inc. (NYSE:ELV) – Research analysts at Cantor Fitzgerald decreased their FY2025 earnings per share (EPS) estimates for shares of Elevance Health in a report issued on Friday, January 24th. Cantor Fitzgerald analyst S. James now expects that the company will post earnings of $34.57 per share for the year, down from their previous estimate of $34.65. Cantor Fitzgerald currently has a “Overweight” rating and a $485.00 price target on the stock. The consensus estimate for Elevance Health’s current full-year earnings is $32.95 per share.

Other analysts have also recently issued reports about the stock. Royal Bank of Canada decreased their price objective on shares of Elevance Health from $585.00 to $478.00 and set an “outperform” rating on the stock in a research note on Friday, October 18th. Argus cut Elevance Health from a “buy” rating to a “hold” rating in a report on Friday, October 18th. Mizuho reduced their price objective on Elevance Health from $585.00 to $505.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th. Wells Fargo & Company lowered their target price on Elevance Health from $483.00 to $478.00 and set an “overweight” rating for the company in a research note on Tuesday. Finally, Truist Financial decreased their price objective on shares of Elevance Health from $520.00 to $480.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Four investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $524.47.

Elevance Health Trading Down 1.4 %

Shares of ELV stock opened at $405.67 on Monday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.50 and a current ratio of 1.50. The firm has a fifty day moving average of $386.42 and a 200-day moving average of $460.49. Elevance Health has a 52-week low of $362.21 and a 52-week high of $567.26. The stock has a market cap of $94.08 billion, a price-to-earnings ratio of 14.79, a P/E/G ratio of 1.11 and a beta of 0.84.

Elevance Health (NYSE:ELV) last posted its quarterly earnings data on Thursday, January 23rd. The company reported $3.84 EPS for the quarter, topping analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a return on equity of 19.56% and a net margin of 3.68%.

Elevance Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Monday, March 10th will be paid a dividend of $1.71 per share. The ex-dividend date is Monday, March 10th. This is a positive change from Elevance Health’s previous quarterly dividend of $1.63. This represents a $6.84 annualized dividend and a dividend yield of 1.69%. Elevance Health’s payout ratio is currently 23.77%.

Hedge Funds Weigh In On Elevance Health

Large investors have recently made changes to their positions in the company. Stephens Inc. AR raised its position in shares of Elevance Health by 0.7% in the fourth quarter. Stephens Inc. AR now owns 21,034 shares of the company’s stock valued at $7,760,000 after buying an additional 156 shares in the last quarter. Alliance Wealth Advisors LLC raised its holdings in Elevance Health by 29.2% in the 4th quarter. Alliance Wealth Advisors LLC now owns 903 shares of the company’s stock valued at $333,000 after acquiring an additional 204 shares in the last quarter. Empirical Finance LLC lifted its position in shares of Elevance Health by 10.4% during the 4th quarter. Empirical Finance LLC now owns 10,300 shares of the company’s stock valued at $3,800,000 after acquiring an additional 973 shares during the period. Empowered Funds LLC grew its holdings in shares of Elevance Health by 47.4% during the 4th quarter. Empowered Funds LLC now owns 61,872 shares of the company’s stock worth $22,825,000 after purchasing an additional 19,907 shares in the last quarter. Finally, Kingsview Wealth Management LLC increased its position in shares of Elevance Health by 36.2% in the fourth quarter. Kingsview Wealth Management LLC now owns 23,501 shares of the company’s stock worth $8,670,000 after purchasing an additional 6,250 shares during the period. Institutional investors own 89.24% of the company’s stock.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.